Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1798052 | 0.82 | ALDH1A1 (0.51) | ALDH1A1POLBNPSR1MAPK1MAPT | |
| SCHEMBL8067779 | 0.75 | TAAR1 (0.42) | ACHESMN1; SMN2 | |
| SCHEMBL8068905 | 0.70 | SMN1; SMN2 (0.30) | NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL8058657 | 0.70 | — | — | |
| SCHEMBL7521956 | 0.70 | GAA (0.30) | ALDH1A1MAPK1GAAATM | |
| SCHEMBL18300413 | 0.64 | DRD2 (0.55) | ALDH1A1NPSR1MAPK1LMNAMAPT | |
| SCHEMBL141255 | 0.62 | HSD17B10 (0.44) | ATM | |
| SCHEMBL180596 | 0.62 | — | — | |
| SCHEMBL24278859 | 0.61 | KDM1A (0.35) | — | |
| SCHEMBL30090937 | 0.60 | RBP4 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5889007-A | CHEMISENSITIZING AGENTS; CANCER THERAPY DRUG RESISTANCE | SYNTEX (U.S.A.) INC. (US) | 1999-03-30 | — | — | US | disclosed |
| US-5874434-A | SENSITIZERS FOR CANCER DRUGS | SYNTEX (U.S.A.) INC. (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0695293-B1 | 10,11-METHANODIBENZOSUBERANE DERIVATIVES USED AS CHEMOSENSITIZING AGENTS | SYNTEX INC (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0866063-A1 | 10, 11-Methanodibenzosuberane derivatives used as chemosensitizing agents | SYNTEX (U.S.A.) INC. (US) | 1998-09-23 | — | — | EP | disclosed |
| US-5654304-A | CHEMOSENSITIZING AGENTS; CANCER THERAPY; DRUG RESISTANCE | SYNTEX (U.S.A.) INC. (US) | 1997-08-05 | — | — | US | disclosed |
| US-5643909-A | CHEMICAL SENSITIZERS FOR CANCER CHEMOTHERAPY FOR MULTIDRUG RESISTANCE | SYNTEX (U.S.A.) INC. (US) | 1997-07-01 | — | — | US | disclosed |
| EP-0695293-A1 | 10,11-METHANODIBENZOSUBERANE DERIVATIVES USED AS CHEMOSENSITIZING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1996-02-07 | — | — | EP | disclosed |
| WO-1994024107-A1 | 10,11-METHANODIBENZOSUBERANE DERIVATIVES USED AS CHEMOSENSITIZING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1994-10-27 | — | — | WO | disclosed |